Clinical Trial Update: Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated a topical 5-aminolevulinic acid nanoemulsion as a light-sensitizing cream for photodynamic therapy in Lentigo Maligna and has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lentigo Maligna

Drugs mentioned

• 5-aminolevulinic acid nanoemulsion topical cream (5-aminolevulinic acid nanoemulsion)

Snippet

Sponsor: Joint Authority for Päijät-Häme Social and Health Care | Conditions: Lentigo Maligna | Phase 4 | Status: COMPLETED